LSL Web-Exclusive Content

  1. The 3 Stages Of Decentralized Trial Maturity 2/1/2023

    Decentralized clinical trials (DCTs) offer clear benefits to patients and the overall success of the trial, but it can be difficult to know how to address this challenge. This three-stage framework approach will enable you to assess your organization’s current clinical trial innovation maturity and build a plan from there.

  2. This Is Not The 90's Neuroscience 1/31/2023

    Over my 20-plus years in the industry, I have witnessed incredible growth in many therapeutic areas, and I’m excited to see neuroscience taking center stage once again.

  3. Pricing Strategy For New Anti-Alzheimer's Drug Puts Access Community On The Defensive 1/25/2023

    Equipped with the knowledge that the payer community has heavily restricted access to amyloid directed antibodies, Biogen and Eisai have elected to employ a very different strategy for Leqembi.

  4. 4 “Hot Takes” On Cell & Gene Therapy Manufacturing From Advanced Therapies Week 2023 1/24/2023

    There is truly no article more difficult to write than a takeaway article from a conference. But as I recently spent the past week attending various panels and hearing different perspectives at Phacilitate’s Advanced Therapies Week, I wanted to attempt to do “the impossible” (for me): Share four of the burning manufacturing takeaways that jumped out at me most during the week.

  5. How One Pharma Exec Uses Her Father's Cancer Experience To Better Patients' Clinical Journeys 1/23/2023

    Until pharmaceutical executive Christina DiArcangelo's father became a Stage 4 oncology patient, she wasn't wholly aware of the shortcomings of clinical trials. Now, buoyed by personal experience, she's dedicating her professional and personal pursuits to improving the patient experience.

  6. How Can Clinical Research Better Navigate Healthcare Deserts? 1/17/2023

    Large swaths of the U.S. remain healthcare deserts, where access to clinical sites, pharmacies, and hospitals is limited. This contributes to underrepresentation in clinical research. What are the roles of technology and community outreach, and what are some current industry efforts to address it?

  7. Frequent Deficiencies In GMP Inspections, Part 3 1/16/2023

    Don't let cleaning and disinfection methods work against you. Without a system to track cleaning chemicals and equipment, how do you know they haven't expired?

  8. Being Prepared: Business Continuity Planning In The Life Science Industry 1/11/2023

    Business continuity planning (BCP) ahead of the next pandemic or natural disaster is essential to ensure the success of any enterprise, but it's particularly crucial for companies in the life science industry.

  9. Will ESG Be 2023's Hottest Business Topic In Bio/Pharma? 1/6/2023

    Sustainability used to be just about saving the planet. Today it has morphed into an umbrella term for environmental, social, and governance (ESG) issues. Mentions of ESG and related topics in pharma companies’ filings more than tripled between 2016 and 2021. What are the commitments that companies are making, and which Big Pharma companies are making those commitments?

  10. Two Straightforward Ways To Improve DE&I In Clinical Trials 12/27/2022

    We don’t have to wait for federal guidance, additional DHT, or new innovations. We have the tools to begin to address the lack of trust and limited data and incorporate them into diversity plans for clinical trials today. Here's how.